Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The compound is not yet approved as a pharmaceutical in Canada or the US, with FDA approval expected in 2026 to 2027
Patients are discovering the drug a GLP-1, glucose-dependent insulinotropic polypeptide, and glucagon agonist through social media, purchasing it from vendors online, and arriving at clinic appointments either asking about it or disclosing they are already using it
The starting dose is not where results happen
That broader mechanism is a big part of why so many researchers see it as a step beyond earlier single-pathway compounds
Youre Still Early in Treatment The first few weeks may not accurately reflect your long-term results
US$ 25.97
US$ 24.90
US$ 26.66
US$ 29.16
US$ 23.54
US$ 29.18
US$ 27.40
